Kiniksa Pharmaceuticals
KNSA
KNSA
103 hedge funds and large institutions have $346M invested in Kiniksa Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $330M → $346M (+$15.8M)
2.46% less ownership
Funds ownership: 89.31% → 86.85% (-2.5%)
Holders
103
Holding in Top 10
–
Calls
$3.67M
Puts
$2.79M
Top Buyers
| 1 | +$4.28M | |
| 2 | +$3.57M | |
| 3 | +$3.53M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$2.87M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.68M |
Top Sellers
| 1 | -$6.7M | |
| 2 | -$5.18M | |
| 3 | -$3.35M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$3.31M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$2.67M |